Amedisys Updates 2006 Guidance
09 February 2006 - 5:00AM
PR Newswire (US)
BATON ROUGE, La., Feb. 8 /PRNewswire-FirstCall/ -- Amedisys, Inc.
(Nasdaq: "AMED" or the "Company"), one of America's leading home
health nursing companies, today provided an update on earnings
guidance for full-year 2006. This updated guidance takes into
consideration an approximate 0.8 percent total reimbursement
increase, as compared with the approximate 2.5 percent increase
Amedisys expected to receive in 2006, and assumed in previously
issued guidance. The 0.8 percent reimbursement increase for 2006
takes into account the proposed Deficit Reduction Act's one-year
Medicare home health reimbursement freeze in 2006 enhanced by the
five percent rural add-on. It should be noted, though, that, as it
relates to Amedisys, the rural add-on has been negatively impacted
by a revised definition of what constitutes a rural area, and other
wage index changes applying to 2006. The initial impact of the
recent Deficit Reduction Act on Amedisys, inclusive of both the
one-year market basket freeze and the five percent rural add-on,
would reduce full-year 2006 earnings by approximately $0.28 cents
per share. However, the Company believes it can partially offset
this impact, and now expects that earnings for full-year 2006 will
be between $2.33 and $2.43 per share, on net service revenue of
approximately $510 million. "We will concentrate our efforts on
continuing to improve our competitive position in markets we serve,
as well as establishing new market presence. We expect to continue
our growth, both internal and through appropriate acquisitions, and
we will maintain our ongoing focus on the efficiency of our
operations," said William F. Borne, Chief Executive Officer of
Amedisys. "Amedisys has a track record for generating organic
growth, and we are especially pleased with our internal growth of
18 percent in Medicare admissions for 2005." Amedisys, Inc., a
leading provider of home health nursing services, is headquartered
in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq
National Market System under the symbol "AMED". This press release
includes statements that may constitute "forward- looking"
statements, usually containing the words "believe," "estimate,"
"project," "expect" or similar expressions. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such
differences include, but are not limited to, continued acceptance
of the Company's services in the marketplace, competitive factors,
changes in government reimbursement procedures, dependence upon
third-party vendors, and other risks discussed in the Company's
periodic filings with the Securities and Exchange Commission. By
making these forward- looking statements, the Company undertakes no
obligation to update these statements for revisions or changes
after the date of this release. Additional information on the
Company can be found on the World Wide Web at:
http://www.amedisys.com/ Contact: Amedisys, Inc. Noonan Russo Chief
Financial Officer Investors/Media Gregory H. Browne Brian Ritchie
225.292.2031 212.845.4269 DATASOURCE: Amedisys, Inc. CONTACT:
Gregory H. Browne, Chief Financial Officer, Amedisys, Inc.,
+1-225-292-2031, ; Brian Ritchie, Investors/Media, Noonan Russo,
+1-212-845-4269, Web site: http://www.amedisys.com/
Copyright